Search results (1)
« Back to PublicationsCombinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells.
Journal article
He M. et al, (2022), J Immunother Cancer, 10
Journal article
He M. et al, (2022), J Immunother Cancer, 10